bioRxiv · 10.64898/2026.06.10.731360
GALILEO: Embodied AI scientist for autonomous therapeutic discovery in dynamic membrane systems
Abstract
Generalizable Agentic Laboratory Intelligence for Learning, Experimentation, and Optimization (GALILEO) closes the prediction-to-intervention gap in therapeutic peptide discovery. Unlike prior AI-scientist systems, GALILEO couples an Observation-Thought-Action-Summary (OTAS) reasoning loop with robotic peptide synthesis and multimodal phenotyping. Candidate peptides are retrieved from a clinically informed peptide prior (CPP) and locally edited through auditable operations. GALILEO autonomously prioritized LRRC8C and SLC25A1 branches and used wet-lab feedback to update target beliefs, sequence policies, assay choices, and mechanism hypotheses. Peptides generated under this framework blocked LRRC8C currents, perturbed osmolyte/redox homeostasis, and promoted tumor-dependent T-cell activation, while SLC25A1 peptides disrupted citrate-export metabolism, reduced extracellular acidosis, and enhanced CD8+ T-cell function. These results establish retrieval-and-editing-based physical learning as a route for auditable, experimentally grounded interventions and transferable membrane-blocker rules.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jiang, N., Wei, R., Xiao, H., Yin, Z., Wang, X., Cui, T., Shao, K., Zhou, J., Fan, J., Torr, P., Wu, Y., Gao, Q.. 2026-06-12. GALILEO: Embodied AI scientist for autonomous therapeutic discovery in dynamic membrane systems. https://doi.org/10.64898/2026.06.10.731360
Cite the original work for its findings. Save a collection to share your selection of sources.